Dr. Eduardo Sanchez on ACC-AHA 2019 Prevention Guidelines
Eduardo Sanchez, M.D., M.P.H., FAAFP serves as Chief Medical Officer (CMO) for Prevention and Chief of the Center for Health Metrics and Evaluation for the American Heart Association (AHA).
American Heart Association Immediate Past President (2021-2022), Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is a professor of neurology and epidemiology at Columbia University’s Vagelos College of Physicians and Surgeons and attending neurologist at New York-Presbyterian/Columbia University Irving Medical Center in New York City.
Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is American Heart Association Chief Clinical Science Officer and a past president (served as president July 2020 - June 2021). On September 1, 2022, Dr. Elkind took a leave of absence from his position as professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY to join the Association in this current role.
Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is American Heart Association Chief Clinical Science Officer and a past president (served as president July 2020 - June 2021). On September 1, 2022, Dr. Elkind took a leave of absence from his position as professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY to join the Association in this current role.
American Heart Association Immediate Past President (2021-2022), Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is a professor of neurology and epidemiology at Columbia University’s Vagelos College of Physicians and Surgeons and attending neurologist at New York-Presbyterian/Columbia University Irving Medical Center in New York City.
Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is American Heart Association Chief Clinical Science Officer and a past president (served as president July 2020 - June 2021). On September 1, 2022, Dr. Elkind took a leave of absence from his position as professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY to join the Association in this current role.
Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is American Heart Association Chief Clinical Science Officer and a past president (served as president July 2020 - June 2021). On September 1, 2022, Dr. Elkind took a leave of absence from his position as professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY to join the Association in this current role.
Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is American Heart Association Chief Clinical Science Officer and a past president (served as president July 2020 - June 2021). On September 1, 2022, Dr. Elkind took a leave of absence from his position as professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY to join the Association in this current role.
Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is American Heart Association Chief Clinical Science Officer and a past president (served as president July 2020 - June 2021). On September 1, 2022, Dr. Elkind took a leave of absence from his position as professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY to join the Association in this current role.
American Heart Association Immediate Past President (2021-2022), Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is a professor of neurology and epidemiology at Columbia University’s Vagelos College of Physicians and Surgeons and attending neurologist at New York-Presbyterian/Columbia University Irving Medical Center in New York City.
Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is American Heart Association Chief Clinical Science Officer and a past president (served as president July 2020 - June 2021). On September 1, 2022, Dr. Elkind took a leave of absence from his position as professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY to join the Association in this current role.
American Heart Association Immediate Past President (2021-2022), Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, is a professor of neurology and epidemiology at Columbia University’s Vagelos College of Physicians and Surgeons and attending neurologist at New York-Presbyterian/Columbia University Irving Medical Center in New York City.
Dr. Hidalgo - ataques cardacos durante la temporada festiva de invierno (holiday heart attacks in Spanish)
Bertha Hidalgo, Ph.D., M.P.H. y profesora asociada del departamento de Epidemiología de la Universidad de Alabama en Birmingham comments in Spanish on increased heart attacks during the holiday season.
American Heart Association adds sleep to cardiovascular health checklist - American Heart Association Presidential Advisory
American Heart Association President Donald M. Lloyd-Jones, M.D., Sc.M., FAHA, who led the advisory writing group and is chair of the department of preventive medicine, the Eileen M. Foell Professor of Heart Research and professor of preventive medicine, medicine and pediatrics at Northwestern University’s Feinberg School of Medicine in Chicago explains Life’s Essential 8™.
Lourdes Nuñez, M.D., is currently the Medical Director of Encompass Health Rehabilitation Hospital of Miami, Florida, where she cares for patients undergoing rehabilitation after stroke, trauma, and general medical problems including heart disease, diabetes, and oncology.
Lourdes Nuñez, M.D., is currently the Medical Director of Encompass Health Rehabilitation Hospital of Miami, Florida, where she cares for patients undergoing rehabilitation after stroke, trauma, and general medical problems including heart disease, diabetes, and oncology.
Dr. Nuñez on heart-brain health risk factors en Español
Lourdes Nuñez, M.D., is currently the Medical Director of Encompass Health Rehabilitation Hospital of Miami, Florida, where she cares for patients undergoing rehabilitation after stroke, trauma, and general medical problems including heart disease, diabetes, and oncology.
Lourdes Nuñez, M.D., is currently the Medical Director of Encompass Health Rehabilitation Hospital of Miami, Florida, where she cares for patients undergoing rehabilitation after stroke, trauma, and general medical problems including heart disease, diabetes, and oncology.
Lourdes Nuñez, M.D., is currently the Medical Director of Encompass Health Rehabilitation Hospital of Miami, Florida, where she cares for patients undergoing rehabilitation after stroke, trauma, and general medical problems including heart disease, diabetes, and oncology.
Dr. Robert Eckel on avoiding a heart attack or stroke over the holidays - TV spot
Video news release on avoiding a heart attack or stroke over the holiday season including a soundite by Dr. Robert Eckel, American Diabetes Association president of medicine and science and an endocrinologist at the University of Colorado School of Medicine and Past President of the American Heart Association
Sally Haskell, M.D., Deputy Chief Officer for Clinical Operations and Director of Comprehensive Women’s Health in the Office of Women’s Health, Veterans Health Administration. In this role she directs policy and implementation for Comprehensive Women’s Health nationally.
Dr. Elkind offers insight into a new study on the consumption of sugar-sweetened beverages. He is the 2019-20 President-elect of the American Heart Association, Professor of Neurology at Columbia University College of Physicians and Surgeons in New York City and an Attending Neurologist on the Stroke Service at the New York-Presbyterian Hospital.
Paul Muntner, Ph.D., chair of the writing group for the updated American Heart Association scientific statement on blood pressure measurement in humans, published in the American Heart Association journal Hypertension.
Paul Muntner, Ph.D., chair of the writing group for the updated American Heart Association scientific statement on blood pressure measurement in humans, published in the American Heart Association journal Hypertension.
Paul Muntner, Ph.D., chair of the writing group for the updated American Heart Association scientific statement on blood pressure measurement in humans, published in the American Heart Association journal Hypertension.
Kiran Musunuru, M.D., Ph.D., M.P.H., chair of the writing committee for the scientific statement from the American Heart Association (which summarizes the state-of-the-science of genomic medicine) and an associate professor of cardiovascular medicine and genetics at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia.
Kiran Musunuru, M.D., Ph.D., M.P.H., chair of the writing committee for the scientific statement from the American Heart Association (which summarizes the state-of-the-science of genomic medicine) and an associate professor of cardiovascular medicine and genetics at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia.
Kiran Musunuru, M.D., Ph.D., M.P.H., chair of the writing committee for the scientific statement from the American Heart Association (which summarizes the state-of-the-science of genomic medicine) and an associate professor of cardiovascular medicine and genetics at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia.
Kiran Musunuru, M.D., Ph.D., M.P.H., chair of the writing committee for the scientific statement from the American Heart Association (which summarizes the state-of-the-science of genomic medicine) and an associate professor of cardiovascular medicine and genetics at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia.
Kiran Musunuru, M.D., Ph.D., M.P.H., chair of the writing committee for the scientific statement from the American Heart Association (which summarizes the state-of-the-science of genomic medicine) and an associate professor of cardiovascular medicine and genetics at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia.
